| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.2 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.26 | 0.2 |